Biovie BIVI
NASDAQ BIVI
$1.95 +0.09 (+4.84%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biovie (BIVI) Shares Outstanding (2013 - 2026)

Biovie (BIVI) posted Shares Outstanding (Entity) of $7.5 million for Q1 2026, little changed sequentially from $7.5 million in Q4 2025, and up 306.81% YoY from $1.9 million in Q1 2025.

Biovie (BIVI) Shares Outstanding (2013 - 2026) Analysis & Trends

Biovie has reported Shares Outstanding (Entity) for 14 years, with the latest figure at $7.5 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 306.81% year-over-year to $7.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.5 million (up 306.81% YoY) and the FY2025 annual result came in at $1.5 million, up 226.96% from the prior year.
  • Shares Outstanding (Entity) was little changed at $7.5 million in Q1 2026 per BIVI's latest filing, from $7.5 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $7.5 million in Q1 2026 and troughed at $249841.0 in Q1 2022.
  • A 5-year average of $1.7 million and a median of $448011.0 in 2024 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) grew 15.54% in 2023, then soared 714.95% in 2025.
  • Over 5 years, Shares Outstanding (Entity) stood at $345043.0 in 2022, then advanced by 15.54% to $398667.0 in 2023, then surged by 363.5% to $1.8 million in 2024, then surged by 308.24% to $7.5 million in 2025, then advanced by 0.01% to $7.5 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $7.5 million, $7.5 million, and $5.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.19 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 111.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.61 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 445.06 Mn
10 Biovie 14.17 Mn 14.17 Mn - 7.25 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 7.54 Mn
Mar 31, 2026 7.54 Mn
Dec 31, 2025 7.92 Mn
Sep 30, 2025 5.21 Mn
Jun 30, 2025 1.48 Mn
Mar 31, 2025 1.85 Mn
Dec 31, 2024 1.57 Mn
Sep 30, 2024 639,836.00
Jun 30, 2024 451,853.00
Mar 31, 2024 448,011.00
Dec 31, 2023 381,708.00
Sep 30, 2023 367,428.00
Jun 30, 2023 324,835.00
Mar 31, 2023 353,256.00
Dec 31, 2022 311,688.00
Sep 30, 2022 272,124.00
Jun 30, 2022 246,626.00
Mar 31, 2022 249,841.00
Dec 31, 2021 249,624.00
Sep 30, 2021 237,199.00